一种实验性肺癌 药物在早期试验中减缩肿瘤, 显示出对晚期病例的希望。 An experimental lung cancer drug shrank tumors in early trials, showing promise for advanced cases.

一种新的实验药物在肺癌病人的早期试验中显示肿瘤显著减少,有些参与者的肿瘤严重萎缩。 A new experimental drug has demonstrated significant tumor reduction in early trials for lung cancer patients, with some participants experiencing substantial shrinkage of their tumors. 一项小型临床研究的结果表明,治疗可为患有晚期疾病的患者提供有希望的新选择。 The results, from a small clinical study, suggest the treatment may offer a promising new option for those with advanced disease. 研究人员说需要进行进一步测试,以确认长期的有效性和安全性。 Researchers say further testing is needed to confirm long-term effectiveness and safety.